Influence of the Time Interval until the Start of adjuvant Chemotherapy on Overall Survival in Patients with triple-negative Breast Cancer

被引:0
|
作者
Hatzipanagiotou, M. E. [1 ]
Pigerl, M. C. [1 ]
Gerken, M. [2 ,3 ]
Raepple, S. [1 ]
Zeltner, V [1 ]
Ugocsai, P. [1 ]
Ortmann, O. [1 ]
Klinkhammer-Schalke, M. [2 ,3 ]
Seitz, S. [1 ]
机构
[1] Lehrstuhl Univ Regensburg, Caritas Krankenhaus St Josef, Klin Frauenheilkunde & Geburtshilfe, Regensburg, Germany
[2] Univ Regensburg, Inst Qual Management & Hlth Serv Res, Tumor Ctr, Regensburg, Germany
[3] Bavarian Hlth & Food Safety Author, Reg Ctr Regensburg, Bavarian Canc Registry, Regensburg, Germany
关键词
D O I
10.1055/s-0043-1768845
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
P49
引用
收藏
页码:739 / 740
页数:2
相关论文
共 50 条
  • [21] Clinical correlates of 'BRCAness' in triple-negative breast cancer of patients receiving adjuvant chemotherapy
    Oonk, A. M. M.
    van Rijn, C.
    Smits, M. M.
    Mulder, L.
    Laddach, N.
    Savola, S. P.
    Wesseling, J.
    Rodenhuis, S.
    Imholz, A. L. T.
    Lips, E. H.
    ANNALS OF ONCOLOGY, 2012, 23 (09) : 2301 - 2305
  • [22] Outcome of patients with triple-negative breast cancer who did not receive adjuvant chemotherapy
    Izci, Hava
    Ardui, Jan
    Laenen, Annouschka
    Verdoodt, Freija
    Floris, Giuseppe
    Slembrouck, Laurence
    Vergote, Ignace
    Smeets, Ann
    Van Nieuwenhuysen, Els
    Han, Sileny
    Nevelsteen, Ines
    Weltens, Caroline
    Berteloot, Patrick
    Punie, Kevin
    Wildiers, Hans
    Neven, Patrick
    CANCER RESEARCH, 2020, 80 (04)
  • [23] Association between lincRNA expression and overall survival for patients with triple-negative breast cancer
    Ping, Jie
    Huang, Shuya
    Wu, Jie
    Bao, Pingping
    Su, Timothy
    Gu, Kai
    Cai, Hui
    Guo, Xingyi
    Lipworth, Loren
    Blot, William J.
    Zheng, Wei
    Cai, Qiuyin
    Shu, Xiao-Ou
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (03) : 769 - 777
  • [24] Race Not a Factor in Overall Survival in Patients With Triple-Negative Breast Cancer: A Retrospective Review
    Glover-Collins, Katherine
    Starlard-Davenport, Athena
    Mahkoul, Issam
    Hutchins, Laura
    Westbrook, Kent
    Korourian, Soheila
    Enoch, Kimberly
    Preston, Michael
    Gardner, Kenneth
    Klimberg, V. Suzanne
    Henry-Tillman, Ronda
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : 52 - 52
  • [25] Association between lincRNA expression and overall survival for patients with triple-negative breast cancer
    Jie Ping
    Shuya Huang
    Jie Wu
    Pingping Bao
    Timothy Su
    Kai Gu
    Hui Cai
    Xingyi Guo
    Loren Lipworth
    William J. Blot
    Wei Zheng
    Qiuyin Cai
    Xiao-Ou Shu
    Breast Cancer Research and Treatment, 2021, 186 : 769 - 777
  • [26] The effect of delayed adjuvant chemotherapy on relapse of triple-negative breast cancer
    Li, Shuang
    Ma, Ding
    Shi, Hao-Hong
    Yu, Ke-Da
    Zhang, Qiang
    JOURNAL OF THORACIC DISEASE, 2018, 10 (05) : 2837 - 2841
  • [27] Efficacy of Sequential Capecitabine on Adjuvant Chemotherapy of Triple-Negative Breast Cancer
    Xi, Xun
    Huang, Xingwei
    Yuan, Huozhong
    Ni, Jun
    Yang, Fulan
    JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
  • [28] The Role of Adjuvant Chemotherapy for Elderly Women with Triple-Negative Breast Cancer
    Lan, Tian
    Guo, Qiusheng
    Lu, Yunyan
    Gu, Junwei
    Shao, Xiying
    Xu, Haibin
    Hu, Zujian
    CANCER RESEARCH, 2023, 83 (05)
  • [29] The Influence of Time to Completion of Chemotherapy on Survival in Patients with Triple Negative Stage III Breast Cancer
    De Los Santos, J.
    Hinton, B.
    Carpenter, J.
    LoBuglio, A.
    Falkson, C.
    Keene, K.
    Meredith, R.
    Krontiras, H.
    Bland, K.
    Wang, C.
    Kim, Y.
    Forero, A.
    CANCER RESEARCH, 2010, 70
  • [30] Comparison of the effectiveness of neoadjuvant chemotherapy and adjuvant chemotherapy for improving prognosis in triple-negative breast cancer patients
    Li, Wangbin
    Chang, Yuwei
    Bai, Xiaohui
    Cao, Hongxin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (08): : 3978 - 3989